Compounds > dermatan sulfate
Page last updated: 2024-08-23

dermatan sulfate and Hematologic Malignancies

dermatan sulfate has been researched along with Hematologic Malignancies in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Ashizawa, M; Fujiwara, SI; Hatano, K; Hayakawa, J; Ikeda, T; Ishihara, Y; Ito, S; Kanda, Y; Kawaguchi, SI; Kawasaki, Y; Mashima, K; Minakata, D; Morita, K; Muroi, K; Nagayama, T; Nakano, H; Nakasone, H; Ochi, SI; Oh, I; Ohmine, K; Ohmori, T; Sato, K; Sugimoto, M; Toda, Y; Umino, K; Yamamoto, C; Yamasaki, R1
Amaki, J; Ando, K; Aoyama, Y; Hara, R; Ichiki, A; Kawada, H; Kawai, H; Machida, S; Ogawa, Y; Onizuka, M; Toyosaki, M1
Doisaki, S; Kato, K; Matsumoto, K; Muramatsu, H; Sakaguchi, H; Watanabe, N; Yoshida, N1

Other Studies

3 other study(ies) available for dermatan sulfate and Hematologic Malignancies

ArticleYear
Comparison of Danaparoid Sodium and Synthetic Protease Inhibitors for the Treatment of Disseminated Intravascular Coagulation Associated with Hematological Malignancies: A Retrospective Analysis.
    Acta haematologica, 2020, Volume: 143, Issue:3

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Blood Component Transfusion; Chondroitin Sulfates; Dermatan Sulfate; Disseminated Intravascular Coagulation; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hematologic Neoplasms; Hemorrhage; Heparitin Sulfate; Humans; Male; Middle Aged; Plasma; Protease Inhibitors; Prothrombin Time; Retrospective Studies; Treatment Outcome

2020
Danaparoid reduces the incidence of hematopoietic stem cell transplantation-associated thrombotic microangiopathy.
    Bone marrow transplantation, 2017, Volume: 52, Issue:2

    Topics: Adolescent; Adult; Chondroitin Sulfates; Dermatan Sulfate; Female; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Heparitin Sulfate; Humans; Incidence; Male; Middle Aged; Thrombotic Microangiopathies

2017
Danaparoid as the prophylaxis for hepatic veno-occlusive disease after allogeneic hematopoietic stem cell transplantation in childhood hematological malignancy.
    Pediatric blood & cancer, 2010, Dec-01, Volume: 55, Issue:6

    Topics: Adolescent; Child; Child, Preschool; Chondroitin Sulfates; Dermatan Sulfate; Female; Fibrinolytic Agents; Follow-Up Studies; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Heparitin Sulfate; Hepatic Veno-Occlusive Disease; Humans; Infant; Male; Prognosis; Retrospective Studies; Survival Rate; Transplantation, Homologous

2010